Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features

  • participants needed
  • sponsor
    Senseonics, Inc.
Updated on 2 February 2023
continuous glucose monitoring


A Prospective, Multicenter Evaluation of Accuracy and Safety of the Eversense CGM System with Enhanced Features. The purpose of this clinical investigation is to evaluate the accuracy of the Eversense 524 Continuous Glucose Monitoring System (Eversense 524 CGM System) with next generation feature enhancements compared to reference glucose measurements. The investigation will also evaluate safety of the Eversense 524 CGM System usage.

Condition Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Treatment Continuous Glucose Monitoring System
Clinical Study IdentifierNCT05131139
SponsorSenseonics, Inc.
Last Modified on2 February 2023

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note